Literature DB >> 8304542

Calcium channel antagonists prevent urinary bladder growth and neuroplasticity following mechanical stress.

W D Steers1, M Albo, J B Tuttle.   

Abstract

Cytosolic Ca2+ has been postulated to regulate smooth muscle hypertrophy and growth factor production. Consistent with this hypothesis we report that the Ca2+ channel antagonists verapamil and diltiazem prevent bladder and neuronal growth in rats in response to 3 wk of urethral obstruction. Ca2+ channel blockers prevented 30-45% of the increase in bladder weight, protein, and DNA content found in obstructed animals. Similarly, these drugs produced a 15-27% reduction in area profiles for retrogradely labeled (Fluoro-Gold) motoneurons in the major pelvic ganglia and afferents in the L6-S1 dorsal root ganglia after obstruction. The reduced growth in neuronal areas was attributed, in part, to less nerve growth factor (NGF) in bladders of obstructed rats receiving verapamil (8.5 pg/bladder) or diltiazem (14.5 pg/bladder) compared with obstructed animals not given these drugs (58.2 pg/bladder). The alpha 1-adrenergic antagonist, prazosin, while decreasing voiding frequency in obstructed rats, had no significant impact on bladder weight or neuronal size. These reductions in the increase in bladder hypertrophy and NGF content may be due to altered handling of Ca2+.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8304542     DOI: 10.1152/ajpregu.1994.266.1.R20

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Contractile and cytoskeletal proteins in urinary bladder smooth muscle from rats treated with epidermal growth factor.

Authors:  L Vinte-Jensen; B Uvelius; E Nexø; A Arner
Journal:  Urol Res       Date:  1996

Review 2.  Biofeedback therapy for dysfunctional voiding in children.

Authors:  Joel F Koenig; Patrick H McKenna
Journal:  Curr Urol Rep       Date:  2011-04       Impact factor: 3.092

3.  Calcineurin mediates bladder wall remodeling secondary to partial outlet obstruction.

Authors:  Andy Y Chang; Joanna Sliwoski; Stephan Butler; George Hearn; Jenny Lassmann; Samuel Chacko; Douglas A Canning; Stephen A Zderic
Journal:  Am J Physiol Renal Physiol       Date:  2011-07-20

Review 4.  Mechanistic insights into the role of alpha1adrenergic receptors in lower urinary tract symptoms.

Authors:  Gregory A Michelotti; Debra A Schwinn
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 2.862

Review 5.  Medical therapy for benign prostatic hyperplasia progression.

Authors:  Kevin T McVary
Journal:  Curr Urol Rep       Date:  2002-08       Impact factor: 2.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.